US patent sales up, Monsanto wins big in India, Sisvel and RPX ink major SEP deal, the global patent market in 10 charts - plus much more
After the festive break, IAM is now back and firing on all cylinders. Here are the stories we covered in the week that has just finished
MONDAY 7th January
Canon has made a rare assertion against a major technology company as its head of IP says he sees wilful infringement on the rise and US enforcement becoming more challenging. Read more here
The latest data shows that patent transactions in the US are on the way back up again, with the likes of Samsung, InterDigital and Fortress leading the way. Read more here
TUESDAY 8th January
Touchscreen technology company Immersion has appointed the former head of Nokia’s patent monetisation business as its new CEO. Read more here
Monsanto has emerged victorious at India’s Supreme Court in a biotech case that has been keenly watched by life sciences companies around the world. Read more here
WEDNESDAY 9th January
Maria Varsellona – president of Nokia’s patent business and the company’s chief legal officer – has been confirmed as a keynote speaker at IPBC Global in Boston this June. Read more here
THURSDAY 10th January
Sisvel has signed a major licensing deal with RPX that will give a sub-set of the defensive aggregator’s subscribers access to 700 SEPs and non-essential patents. Read more here
Patent assignments last month and a new technology partnership show there is plenty of opportunity for Microsoft and LG to collaborate. Read more here
New USPTO subject matter guidance meets with industry approval, but may make Congressional 101 action less likely. Read more here
FRIDAY 11th January
Your guide to the global patent market in 10 charts. Read more here
Readiness to arbitrate with Huawei demonstrates InterDigital's FRAND intentions, CEO says in exclusive interview with IAM. Read more here
Uber, Lyft, Pinterest and Slack are among companies planning or actively considering IPOs this year, but in comparison to the past such unicorns are acquiring far fewer patents in the run-up to listing. Read more here